Environ Health Perspect by Wells, Ellen M. et al.




Note to Readers: EHP strives to ensure that all journal content is accessible to all readers. However, 
some figures and Supplemental Material published in EHP articles may not conform to 508 standards due 
to the complexity of the information being presented. If you need assistance accessing journal content, 
please contact ehp508@niehs.nih.gov. Our staff will work with you to assess and meet your accessibility 
needs within 3 working days. 
Supplemental Material 
Cord Blood Methylmercury and Fetal Growth Outcomes in 
Baltimore Newborns: Potential Confounding and Effect 
Modification by Omega-3 Fatty Acids, Selenium, and Sex  
Ellen M. Wells, Julie B. Herbstman, Yu Hong Lin, Jeffery Jarrett, Carl P. Verdon, Cynthia 
Ward, Kathleen L. Caldwell, Joseph R. Hibbeln, Frank R. Witter, Rolf U. Halden, and Lynn R. 
Goldman  
Table of Contents	  
Table S1: Spearman correlation coefficients (p-values) for mercury, selenium and n-3 HUFAs, 
THREE Study, 2004-2005	  
Table S2: Regression coefficient (95% confidence intervals) for MeHg, n-3 HUFAs, selenium, 
and IHg in various multivariable regression models, N=271, THREE Study, 2004-2005	  
Table S3: Adjusted regression coefficient (95% confidence intervals) for ln(MeHg), among the 




Table S1: Spearman correlation coefficients (p-values) for mercury, selenium and n-3 HUFAs, 
THREE Study, 2004-2005 
 MeHg IHg Total Hg n-3 HUFAs Selenium 
MeHg 1.0     
IHg 0.51 (<0.01) 1.0    
Total Hg 0.91 (<0.01) 0.53 (<0.01) 1.0   
n-3 HUFAs 0.23 (<0.01) 0.15 (0.02) 0.26 (<0.01) 1.0  
Selenium -0.02 (0.70) -0.07 (0.24) 0.01 (0.85) 0.19 (<0.01) 1.0 
THREE = Tracking Health Related to Environmental Exposures; MeHg = methyl mercury; IHg = inorganic 
mercury; Total Hg = total mercury; n-3 HUFAs = n-3 highly unsaturated fatty acids.  N=265 due to some missing 




Table S2: Regression coefficient (95% confidence intervals) for MeHg, n-3 HUFAs, selenium, and IHg in various multivariable regression 
models, N=271, THREE Study, 2004-2005 
Outcome and covariate  Model 2a Model 2a + Selenium Model 2a + n-3 HUFAs Model 2a + IHg Model 3b 
Gestational age, days      
Ln(MeHg), µg/L 0.86 (-0.81, 2.54) 0.87 (-0.73, 2.48) 0.38 (-1.33, 2.08) 0.31 (-1.54, 2.16) -0.07 (-1.87, 1.73) 
Selenium, µg/L  0.32 (0.19 0.46)#   0.31 (0.18, 0.45)# 
n-3 HUFAs, µg/mL   0.13 (0.02, 0.24)#  0.07 (-0.03, 0.18) 
Ln(IHg), µg/L    0.63 (-0.26, 1.53) 0.77 (-0.09, 1.63)* 
Birthweight, grams      
Ln(MeHg), µg/L -16.84 (-74.96, 41.27) -15.51 (-73.25, 42.24) -7.72 (-67.27, 51.84) -39.67 (-103.51, 24.17) -29.65 (-93.89, 34.60) 
Selenium, µg/L  5.29 (0.35, 10.23)#   6.72 (1.71, 11.73) 
n-3 HUFAs, µg/mL   -2.57 (-6.34, 1.20)  -3.61 (-7.40, 0.17)* 
Ln(IHg), µg/L    26.40 (-4.66, 57.46)* 31.62 (0.76, 62.48)# 
Length, cm      
Ln(MeHg), µg/L 0.09 (-0.18, 0.37) 0.10 (-0.18, 0.37) 0.15 (-0.13, 0.43) 0.08 (-0.22, 0.39) 0.14 (-0.17, 0.45) 
Selenium, µg/L  0.01 (-0.01, 0.04)   0.02 (-0.01, 0.04) 
n-3 HUFAs, µg/mL   -0.02 (-0.03, 0.002)*  -0.02 (-0.04, -0.0001)# 
Ln(IHg), µg/L    0.01 (-0.14, 0.16) 0.03 (-0.12, 0.18) 
Head circumference, cm      
Ln(MeHg), µg/L -0.14 (-0.33, 0.04) -0.14 (-0.33, 0.04) -0.10 (-0.29, 0.09) -0.21 (-0.42, -0.01)# -0.16 (-0.37, 0.04) 
Selenium, µg/L  0.005 (-0.01, 0.02)   0.01 (-0.01, 0.03) 
n-3 HUFAs, µg/mL   -0.01 (-0.03, -0.002)#  -0.02 (-0.03, -0.003)# 
Ln(IHg), µg/L    0.08 (-0.02, 0.18) 0.09 (-0.01, 0.19)* 
Ponderal index, (g/cm3)×100      
Ln(MeHg), µg/L -0.030 (-0.065, 0.005)* -0.029 (-0.064, 0.006) -0.030 (-0.066, 0.007) -0.045 (-0.084, -0.007)# -0.045 (-0.084, -0.005)# 
Selenium, µg/L  0.002 (-0.001, 0.005)   0.003 (-0.001, 0.006) 
n-3 HUFAs, µg/mL   -0.00003 (-0.002, 0.002)  -0.0004 (-0.003, 0.002) 
Ln(IHg), µg/L    0.018 (-0.001, 0.037)* 0.020 (0.001, 0.039)# 
THREE = Tracking Health Related to Environmental Exposures; HUFA = highly unsaturated fatty acid; MeHg = methylmercury; IHg = inorganic mercury; HUFA = highly 
unsaturated fatty acid; CI = confidence interval.   
Model 2 includes the following covariates: methylmercury, gestational age (except for gestational age outcome), infant sex (entire cohort only), maternal age (quadratic), 
primiparity, prepregnancy body mass index, maternal race, maternal smoking, maternal pregestational and gestational hypertension, and maternal pregestational and gestational 
diabetes.   
Model 3 includes the covariates included in model 2 as well as selenium, n-3 HUFAs, and IHg.  
*p-value <0.10; #p-value ≤0.05. 
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Table S3: Adjusteda regression coefficient (95% confidence intervals) for ln(MeHg), among the full cohort as well as stratum-specific estimates, 
THREE Study, 2004-2005 










Full cohort  β for ln(MeHg) -0.07 (-1.87, 1.73) -29.6 (-93.9, 34.6) 0.14 (-0.17, 0.45) -0.16 (-0.37, 0.04) -0.045 (-0.084, -0.005)# 
Males β for ln(MeHg) 1.42 (-1.21, 4.05) -13.5 (-110.2, 83.3) 0.35 (-0.06, 0.75)* -0.29 (-0.61, 0.020)* -0.063 (-0.12, -0.007)# 
Females β for ln(MeHg) -1.68 (-4.18, 0.83) -38.5 (-124.2, 47.3) -0.02 (-0.52, 0.47) -0.04 (-0.30, 0.22) -0.029 (-0.086, 0.027) 
Full cohort, β for ln(MeHg) -1.59 (-3.99, 0.81) -43.1 (-129.6, 43.5) -0.0004 (-0.42, 0.41) -0.08 (-0.36, 0.20) -0.035 (-0.088, 0.018) 
interaction with sex β for sex 0.48 (-2.66, 3.63) 148.8 (35.8, 261.8)# 0.60 (0.06, 1.14)# 0.32 (-0.04, 0.69)* 0.018 (-0.051, 0.087) 
 β for sex*ln(MeHg) 2.88 (-0.15, 5.91)* 25.5 (-84.2, 135.2) 0.26 (-0.26, 0.79) -0.16 (-0.52, 0.19) -0.018 (-0.085, 0.050) 
 p-value (interaction) 0.062 0.648 0.325 0.360 0.605 
Low n-3 HUFAsb β for ln(MeHg) 0.21 (-2.54, 2.95) 25.2 (-71.0, 121.4) 0.46 (0.005, 0.91)# 0.001 (-0.32, 0.32) -0.056 (-0.113, 0.001)* 
High n-3 HUFAsb β for ln(MeHg) -1.32 (-3.76, 1.12) -88.4 (-185.8, 8.9)* -0.20 (-0.68, 0.28) -0.30 (-0.60, -0.01)# -0.038 (-0.097, 0.022) 
Full cohort, β for ln(MeHg) 0.63 (-1.81, 3.08) 5.8 (-81.5, 93.0) 0.40 (-0.02, 0.81)* 0.01 (-0.27, 0.29) -0.063 (-0.117, -0.010)# 
interaction with β for n-3 HUFAs 0.96 (-2.24, 4.16) -68.4 (-182.5, 45.7) -0.51 (-1.06, 0.03)# -0.41 (-0.77, -0.04)# 0.017 (-0.053, 0.086) 
n-3 HUFAsb β for n-3 HUFAs*ln(MeHg) -0.99 (-4.14, 2.17) -81.7 (-194.4, 30.9) -0.54 (-1.08, -0.01)* -0.37 (-0.74, -0.01)# 0.030 (-0.039, 0.099) 
 p-value (interaction) 0.538 0.154 0.048 0.042 0.386 
Low Sec β for ln(MeHg) -0.35 (-3.55, 2.85) -47.2 (-133.9, 39.6) 0.08 (-0.37, 0.54) -0.25 (-0.60, 0.09) -0.050 (-0.105, 0.005)* 
High Sec β for ln(MeHg) -0.07 (-2.00, 1.86) -8.0 (-106.2, 90.1) 0.25 (-0.19, 0.68) -0.07 (-0.32, 0.19) -0.040 (-0.100, 0.021) 
Full cohort, β for ln(MeHg) -0.11 (-2.58, 2.36) -77.8 (-162.9, 7.4)* 0.03 (-0.39, 0.44) -0.27 (-0.55, 0.003)* -0.064 (-0.117, -0.012)# 
interaction with Sec β for Se 4.36 (1.01, 7.71)# 182.0 (64.9, 299.0)# 0.58 (0.02, 1.15)# 0.20 (-0.17, 0.58) 0.061 (-0.011, 0.134)* 
 β for Se*ln(MeHg) 0.24 (-2.98, 3.46) 103.5 (-7.3, 214.4)* 0.25 (-0.28, 0.77) 0.22 (-0.14, 0.58) 0.041 (-0.027, 0.109) 
 p-value (interaction) 0.883 0.067 0.357 0.221 0.238 
MeHg = methylmercury; IHg = inorganic mercury; HUFAs = highly unsaturated fatty acids; THREE = Tracking Health Related to Environmental Exposures; 
CI = confidence interval; Se = selenium. 
Full cohort n=271; females only n=121; males only n=150; low Se only n=140; high Se only n=131; low n-3 HUFAs only n=136; high n-3 HUFAs only n=135. 
aModels adjusted for gestational age (except for gestational age outcome), infant sex (except for models stratified by sex), maternal age (quadratic), primiparity, 
prepregnancy body mass index, maternal race, maternal smoking, maternal pregestational and gestational hypertension, maternal pregestational and gestational 
diabetes, cord serum selenium, cord serum n-3 HUFAs, and cord blood IHg.. 
bLow cord serum n-3 HUFAs: ≤ 50.4 µg/mL; high cord serum n-3 HUFAs: > 50.4 µg/mL. 
cLow cord serum selenium: < 70 µg/L; high cord serum selenium: ≥ 70 µg/L.  
*p <0.10; # p <0.05. 
